These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21528823)

  • 1. A comparison of referral patterns to the pediatric endocrine clinic before and after FDA approval of growth hormone for idiopathic short stature.
    Goldyn AK; Nabhan ZM; Eugster EA
    J Pediatr Endocrinol Metab; 2011; 24(1-2):89-91. PubMed ID: 21528823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Referral pattern of children with short stature to a pediatric endocrine clinic in Kuwait.
    Al-Abdulrazzaq D; Al-Taiar A; Hassan K; Al-Twari B; Al-Osaimi A; Al-Busairi I
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1055-61. PubMed ID: 27442364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/Ethnic Disparities in US Pediatric Growth Hormone Treatment.
    Grimberg A; Lindberg A; Wajnrajch M; Cucchiara AJ; Camacho-Hübner C
    Horm Res Paediatr; 2018; 90(2):102-108. PubMed ID: 30130795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHALLENGES OF SECURING GROWTH HORMONE COVERAGE FOR IDIOPATHIC SHORT STATURE: REVIEW OF THE 7-YEAR EXPERIENCE AT ONE INSTITUTION.
    Chandar MCSR; Kaplowitz PB; Vaidyanathan P
    Endocr Pract; 2019 Feb; 25(2):156-160. PubMed ID: 30383493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR; Shim YS; Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurance coverage, physician recommendations, and access to emerging treatments: growth hormone therapy for childhood short stature.
    Finkelstein BS; Silvers JB; Marrero U; Neuhauser D; Cuttler L
    JAMA; 1998 Mar; 279(9):663-8. PubMed ID: 9496983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology of short stature in Indian children and an assessment of the growth hormone-insulin-like growth factor axis in children with idiopathic short stature.
    Kumar A; Pal A; Kalaivani M; Gupta N; Jain V
    J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1009-1017. PubMed ID: 30130251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment.
    Chae HW; Hwang IT; Lee JE; So CH; Rhie YJ; Lim JS; Kwon EB; Yi KH; Kim EY; Jo CK; Shim KS; Gil HY; Seong MJ; Nam CM; Moon JS; Hwang JS
    Front Endocrinol (Lausanne); 2022; 13():925102. PubMed ID: 36157444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging options in growth hormone therapy: an update.
    Kemp SF; Frindik JP
    Drug Des Devel Ther; 2011; 5():411-9. PubMed ID: 21966214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
    Bang P; Bjerknes R; Dahlgren J; Dunkel L; Gustafsson J; Juul A; Kriström B; Tapanainen P; Aberg V
    Horm Res Paediatr; 2011; 75(5):335-45. PubMed ID: 21228552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.
    Juul A; Bernasconi S; Clayton PE; Kiess W; DeMuinck-Keizer Schrama S;
    Horm Res; 2002; 58(5):233-41. PubMed ID: 12401943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV; Dana K; Frane J; Lippe B
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy.
    Savage MO; Storr HL
    Front Endocrinol (Lausanne); 2021; 12():781044. PubMed ID: 34956092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.